Format
Items per page
Sort by

Send to:

Choose Destination

Links from PubMed

Items: 1 to 20 of 48

1.

Impact of CYP2E1, GSTA1 and GSTP1 gene variants on serum alpha glutathione S-transferase level in patients undergoing anaesthesia.

Mikstacki A, Skrzypczak-Zielinska M, Zakerska-Banaszak O, Tamowicz B, Skibinska M, Molinska-Glura M, Szalata M, Slomski R.

BMC Med Genet. 2016 May 14;17(1):40. doi: 10.1186/s12881-016-0302-6.

2.

The shifting perception on antioxidants: the case of vitamin E and β-carotene.

Vrolijk MF, Opperhuizen A, Jansen EH, Godschalk RW, Van Schooten FJ, Bast A, Haenen GR.

Redox Biol. 2015;4:272-8. doi: 10.1016/j.redox.2014.12.017. Epub 2015 Jan 16. Review.

3.

Long-term administration and efficacy of oxaliplatin with no neurotoxicity in a patient with rectal cancer: Association between neurotoxicity and the GSTP1 polymorphism.

Kitade H, Shimasaki T, Igarashi S, Sakuma H, Mori M, Tomosugi N, Nakai M.

Oncol Lett. 2014 May;7(5):1499-1502. Epub 2014 Feb 18.

4.

Polymorphisms of GSTP1, ERCC2 and TS-3'UTR are associated with the clinical outcome of mFOLFOX6 in colorectal cancer patients.

Kumamoto K, Ishibashi K, Okada N, Tajima Y, Kuwabara K, Kumagai Y, Baba H, Haga N, Ishida H.

Oncol Lett. 2013 Sep;6(3):648-654. Epub 2013 Jul 15.

5.

The glutathione S-transferase P1 341C>T polymorphism and cancer risk: a meta-analysis of 28 case-control studies.

Huang SX, Wu FX, Luo M, Ma L, Gao KF, Li J, Wu WJ, Huang S, Yang Q, Liu K, Zhao YN, Li LQ.

PLoS One. 2013;8(2):e56722. doi: 10.1371/journal.pone.0056722. Epub 2013 Feb 21.

6.

Maternal and offspring xenobiotic metabolism haplotypes and the risk of childhood acute lymphoblastic leukemia.

Nousome D, Lupo PJ, Okcu MF, Scheurer ME.

Leuk Res. 2013 May;37(5):531-5. doi: 10.1016/j.leukres.2013.01.020. Epub 2013 Feb 20.

7.

Sequence Variants and the Risk of Head and Neck Cancer: Pooled Analysis in the INHANCE Consortium.

Chuang SC, Agudo A, Ahrens W, Anantharaman D, Benhamou S, Boccia S, Chen C, Conway DI, Fabianova E, Hayes RB, Healy CM, Holcatova I, Kjaerheim K, Lagiou P, Lazarus P, Macfarlane TV, Mahimkar MB, Mates D, Matsuo K, Merletti F, Metspalu A, Morgenstern H, Muscat J, Cadoni G, Olshan AF, Purdue M, Ramroth H, Rudnai P, Schwartz SM, Simonato L, Smith EM, Sturgis EM, Szeszenia-Dabrowska N, Talamini R, Thomson P, Wei Q, Zaridze D, Zhang ZF, Znaor A, Brennan P, Boffetta P, Hashibe M.

Front Oncol. 2011 Jul 12;1:13. doi: 10.3389/fonc.2011.00013. eCollection 2011.

8.

Glutathione S-transferase Pi expression predicts response to adjuvant chemotherapy for stage C colon cancer: a matched historical control study.

Jankova L, Robertson G, Chan C, Tan KL, Kohonen-Corish M, Fung CL, Clarke C, Lin BP, Molloy M, Chapuis PH, Bokey L, Dent OF, Clarke SJ.

BMC Cancer. 2012 May 28;12:196. doi: 10.1186/1471-2407-12-196.

9.

Serum glutathione S-transferase P1 1 in prediction of cardiac function.

Andrukhova O, Salama M, Rosenhek R, Gmeiner M, Perkmann T, Steindl J, Aharinejad S.

J Card Fail. 2012 Mar;18(3):253-61. doi: 10.1016/j.cardfail.2011.11.003. Epub 2011 Dec 20.

10.

Pharmacogenomics of cisplatin-induced ototoxicity.

Mukherjea D, Rybak LP.

Pharmacogenomics. 2011 Jul;12(7):1039-50. doi: 10.2217/pgs.11.48. Review.

11.

Novel variants in the PRDX6 Gene and the risk of Acute Lung Injury following major trauma.

Rushefski M, Aplenc R, Meyer N, Li M, Feng R, Lanken PN, Gallop R, Bellamy S, Localio AR, Feinstein SI, Fisher AB, Albelda SM, Christie JD.

BMC Med Genet. 2011 May 31;12:77. doi: 10.1186/1471-2350-12-77.

12.

Semi-quantitative analyses of metabolic systems of human colon cancer metastatic xenografts in livers of superimmunodeficient NOG mice.

Kubo A, Ohmura M, Wakui M, Harada T, Kajihara S, Ogawa K, Suemizu H, Nakamura M, Setou M, Suematsu M.

Anal Bioanal Chem. 2011 Jun;400(7):1895-904. doi: 10.1007/s00216-011-4895-5. Epub 2011 Apr 10.

13.

Growth-inhibitory and chemosensitizing effects of the glutathione-S-transferase-π-activated nitric oxide donor PABA/NO in malignant gliomas.

Kogias E, Osterberg N, Baumer B, Psarras N, Koentges C, Papazoglou A, Saavedra JE, Keefer LK, Weyerbrock A.

Int J Cancer. 2012 Mar 1;130(5):1184-94. doi: 10.1002/ijc.26106. Epub 2011 Jul 21.

14.

The 341C/T polymorphism in the GSTP1 gene is associated with increased risk of oesophageal cancer.

Li D, Dandara C, Parker MI.

BMC Genet. 2010 Jun 11;11:47. doi: 10.1186/1471-2156-11-47.

15.
16.

Phase 2 study of canfosfamide in combination with pegylated liposomal doxorubicin in platinum and paclitaxel refractory or resistant epithelial ovarian cancer.

Kavanagh JJ, Levenback CF, Ramirez PT, Wolf JL, Moore CL, Jones MR, Meng L, Brown GL, Bast RC Jr.

J Hematol Oncol. 2010 Mar 11;3:9. doi: 10.1186/1756-8722-3-9.

17.

Induction of glutathione-dependent DNA double-strand breaks by the novel anticancer drug brostallicin.

Guirouilh-Barbat J, Zhang YW, Pommier Y.

Mol Cancer Ther. 2009 Jul;8(7):1985-94. doi: 10.1158/1535-7163.MCT-09-0320. Epub 2009 Jul 7.

18.

Haplotype-tagging single nucleotide polymorphisms in the GSTP1 gene promoter and susceptibility to lung cancer.

Tan XL, Moslehi R, Han W, Spivack SD.

Cancer Detect Prev. 2009;32(5-6):403-15. doi: 10.1016/j.cdp.2009.02.004. Epub 2009 Mar 17.

19.

Dietary chemoprevention strategies for induction of phase II xenobiotic-metabolizing enzymes in lung carcinogenesis: A review.

Tan XL, Spivack SD.

Lung Cancer. 2009 Aug;65(2):129-37. doi: 10.1016/j.lungcan.2009.01.002. Epub 2009 Jan 31. Review.

20.

Genetic associations with hypoxemia and pulmonary arterial pressure in COPD.

Castaldi PJ, Hersh CP, Reilly JJ, Silverman EK.

Chest. 2009 Mar;135(3):737-44. doi: 10.1378/chest.08-1993. Epub 2008 Nov 18.

Format
Items per page
Sort by

Send to:

Choose Destination

Supplemental Content

Write to the Help Desk